Safety study of CAM2038 q1w or q4w exposure to SL BPN/NX in Addiction
This study is completed in the United States, in Australia, in the United Kingdom, .... It is testing CAM2038 q1w or q4w exposure to SL BPN/NX for Addiction.
AddictionDrugFrom 18 Years to 65 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether CAM2038 q1w or q4w exposure to SL BPN/NX may be useful for adults experiencing addiction.
What would participation involve?
Participants may receive CAM2038 q1w or q4w exposure to SL BPN/NX, attend study visits with the research team. The registry lists locations in Australia, in Denmark, and in Germany.
Who is it mainly for?
This study appears to be mainly for adults with addiction.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateNovember 2015
Recruitment status
Completed
Enrollment listed in the registry
228
Sponsor
Braeburn Pharmaceuticals
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Australia, United Kingdom, ...
Age range
From 18 Years to 65 Years
Official registry ID
NCT02672111
Official title
An Open-Label Multicenter Study Assessing the Long-Term Safety of a Once-Weekly and Once-Monthly, Long-Acting Subcutaneous Injection Depot of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
Studikum - Zentrum fur Klinische Studien im Praxiszentrum Friedrichsplatz
Kassel
Site status: Not listed — confirm with the team
Klinik fur Abhangiges Verhalten und Suchtmedizin Zentralinstitut
Mannheim
Site status: Not listed — confirm with the team
Psychosoziale Begleitung - Praxis Boniakowski
Regensburg
Site status: Not listed — confirm with the team
Praxisgemeinschaft
Stuttgart
Site status: Not listed — confirm with the team
Hungary · 2 sites
Clinexpert Kft
Budapest
Site status: Not listed — confirm with the team
XVI. Kerület Kertvárosi Egészségügyi Szolgálata, Addiktológia
Budapest
Site status: Not listed — confirm with the team
Sweden · 2 sites
Metadonsektionen
Stockholm
Site status: Not listed — confirm with the team
Centrallasarettet Vasteras
Västerås
Site status: Not listed — confirm with the team
Taiwan · 3 sites
Jinan Psychiatric Center, Ministry of Health and Welfa
Tainan, Tainan County
Site status: Not listed — confirm with the team
China Medical University Hospita
Taichung
Site status: Not listed — confirm with the team
Taipei City Hospital
Taipei
Site status: Not listed — confirm with the team
United Kingdom · 4 sites
Blackberry Centre Blackberry Hill Hospital
Fishponds, Bristol
Site status: Not listed — confirm with the team
Hellesdon Hospital The Weavers Centre
Hellesdon, Norwich
Site status: Not listed — confirm with the team
NHS Tayside
Dundee
Site status: Not listed — confirm with the team
Lambeth Drug and Alcohol Service Lorraine Hewitt House
London
Site status: Not listed — confirm with the team
United States · 10 sites
Parkway Medical Center
Birmingham, Alabama
Site status: Not listed — confirm with the team
Haleyville Clinical Research LLC
Haleyville, Alabama
Site status: Not listed — confirm with the team
Boyett Health Services Inc
Hamilton, Alabama
Site status: Not listed — confirm with the team
Dr Vijapura and Associates
Jacksonville, Florida
Site status: Not listed — confirm with the team
TRY Research
Maitland, Florida
Site status: Not listed — confirm with the team
Stanley Street Treatment and Resources Inc
Fall River, Massachusetts
Site status: Not listed — confirm with the team
Wellness and Research Center
Belvidere, New Jersey
Site status: Not listed — confirm with the team
Comprehensive Clinical Research
Berlin, New Jersey
Site status: Not listed — confirm with the team
STARS/Columbia University
New York, New York
Site status: Not listed — confirm with the team
Frost Medical Group, LLC
Conshohocken, Pennsylvania
Site status: Not listed — confirm with the team
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT02672111. We help you review the study, but cannot decide medical eligibility.
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with addiction. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving CAM2038 q1w or q4w exposure to SL BPN/NX, CAM2038 q1w or q4w new to BPN treatment. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Are there criteria about substance use or wanting to reduce it?
The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Braeburn Pharmaceuticals, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
